Skip to content
10-Q

Quarterly Report

ArriVent BioPharma, Inc. AVBP

0001558370-25-010975

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 40.57M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 34.46M sh
Shares Diluted Q2 2025 · Jun 30, 2024 33.5M sh
Shares Diluted Q2 2025 · Jun 30, 2024 29.27M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$94.13M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$37.72M
Short Term Investments Q2 2025 · Jun 30, 2025 $122.92M
Short Term Investments Q2 2025 · Dec 31, 2024 $144.57M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $112.77M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $74.29M
Stockholders Equity Q2 2025 · Jun 30, 2025 $249.87M
Stockholders Equity Q2 2025 · Mar 31, 2025 $202.54M
Stockholders Equity Q2 2025 · Dec 31, 2024 $257.65M
Stockholders Equity Q2 2025 · Jun 30, 2024 $296.66M
Stockholders Equity Q2 2025 · Mar 31, 2024 $317.72M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$153.19M
Current Liabilities Q2 2025 · Jun 30, 2025 $19.64M
Current Liabilities Q2 2025 · Dec 31, 2024 $17.27M
Total Liabilities Q2 2025 · Jun 30, 2025 $19.64M
Total Liabilities Q2 2025 · Dec 31, 2024 $17.29M
Current Assets Q2 2025 · Jun 30, 2025 $250.15M
Current Assets Q2 2025 · Dec 31, 2024 $226.98M
Total Assets Q2 2025 · Jun 30, 2025 $269.51M
Total Assets Q2 2025 · Dec 31, 2024 $274.94M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.90
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.78
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.65
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.90
Eps Basic Q2 2025 · Jun 30, 2025 −$2.78
Eps Basic Q2 2025 · Jun 30, 2024 −$0.65
Eps Basic Q2 2025 · Jun 30, 2024 −$1.34
Sga Expense Q2 2025 · Jun 30, 2025 $5.9M
Sga Expense Q2 2025 · Jun 30, 2025 $11.39M
Sga Expense Q2 2025 · Jun 30, 2024 $3.92M
Sga Expense Q2 2025 · Jun 30, 2024 $7.62M
Rd Expense Q2 2025 · Jun 30, 2025 $27.72M
Rd Expense Q2 2025 · Jun 30, 2025 $89.01M
Rd Expense Q2 2025 · Jun 30, 2024 $21.78M
Rd Expense Q2 2025 · Jun 30, 2024 $38.75M
Net Income Q2 2025 · Jun 30, 2025 −$31.4M
Net Income Q2 2025 · Jun 30, 2025 −$95.79M
Net Income Q2 2025 · Mar 31, 2025 −$64.39M
Net Income Q2 2025 · Jun 30, 2024 −$21.87M
Net Income Q2 2025 · Jun 30, 2024 −$39.29M
Net Income Q2 2025 · Mar 31, 2024 −$17.42M
Operating Income Q2 2025 · Jun 30, 2025 −$33.62M
Operating Income Q2 2025 · Jun 30, 2025 −$100.4M
Operating Income Q2 2025 · Jun 30, 2024 −$25.7M
Operating Income Q2 2025 · Jun 30, 2024 −$46.37M